Concomitant Ceftriaxone and Intravenous Calcium Therapy in Infants

Abstract

OBJECTIVE To determine if increased mortality could be detected with the administration of ceftriaxone and IV calcium in infants through an analysis of a large repository of electronic health records. METHODS Patients were split into 3 groups: 1) neonates, 2) infants, and 3) infants <1 year whose age was not specified. Deaths were classified into mutually exclusive categories based on the administration and timing of ceftriaxone and IV calcium. Crude death rates were calculated, and logistic regression modeling was used to calculate adjusted relative odds of death with associated covariates. RESULTS A total of 259,149 infants were identified. Of 79,038 neonates, the proportion of patients that received ceftriaxone and IV calcium within 48 hours who died was 3.8%, compared with 1.95% (IV calcium), 0.3% (ceftriaxone), 1.54% (IV fluids), and 2.03% (parenteral nutrition). For 102,456 infants, the proportions of deaths were 5.47% (ceftriaxone and IV calcium within 48 hours), 0.45% (IV calcium), 0.15% (ceftriaxone), 0.39% (IV fluids), and 5.5% (parenteral nutrition). Multivariate analysis showed increased odds of death in infants who received ceftriaxone and IV calcium within 48 hours, regardless of age, and propensity score–matched analysis showed a more than 2-fold increased risk for death. CONCLUSIONS The increased risk for death following ceftriaxone and IV calcium administration was noted not only in neonates, but among older infants as well.

Significant Published Articles in 2021 for Pharmacy Nutrition Support Practice

“…Eight papers from the primary literature (receiving 5 or more votes) were collectively identified as most important by the author group. [19][20][21][22][23][24][25][26] Results from the sorting process are depicted in Figure 1.…”

Evaluation of side effects of ceftriaxone use in newborns

“…Ancak FDA bu uyarıyı Nisan 2009 yılında yeniden düzenleyerek yayınlanmıştır ve buna göre; seftriakson ve kalsiyum içeren solüsyonlar, infüzyon hatları infüzyonlar arasında uygun bir sıvı ile tamamen yıkandıktan sonra 28 günden büyük hastalara sırayla uygulanabileceğini şeklinde değiştirmiştir 27 . Yakın zamanda yayınlanmış bir çalışmada, seftriakson ve IV kalsiyumun 48 saat içinde birlikte uygulamasını takiben oluşan ölüm risknin (sadece IV kalsiyum, sadece IV seftriakson, sadece IV sıvı ve sadece IV parenteral nutrisyona kıyasla) sadece yenidoğanlarda değil, aynı zamanda daha büyük bebeklerde de yüksek olduğu bildirilmiştir 30 . Bununla beraber, kalsiyum ve seftriakson arasındaki etkileşimin uygulama yolundaki değişikliklerle azaltılıp azaltılamayacağına ait veri yoktur 16,17 .…”